Clinic
Heartland Regional Medical Center
Heartland Regional Medical Center was paid $57.19M by Medicaid between Jan 2018 and Dec 2024, across 204 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 22% of everything it billed.
33Billing provider infoHEARTLAND REGIONAL MEDICAL CENTER
SAINT JOSEPH, MO 64506
SAINT JOSEPH, MO 64506
33aNPI1437259694assigned 09/25/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$57.19M
24GClaims705,707
24DCodes billed204
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Missouri
Rank by total paid#1 of 38
Median peer was paid$14K
This provider vs. median4,107×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,141 | $13.67M | |
| 2019 | 72,329 | $11.06M | |
| 2020 | 62,722 | $6.01M | |
| 2021 | 85,066 | $2.91M | |
| 2022 | 109,794 | $7.94M | |
| 2023 | 170,205 | $8.89M | |
| 2024incomplete | 116,450 | $6.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 22% | 194,045 | 161,579 | $12.64M |
| X4011 | State-specific procedure code | 15% | 17,841 | 16,724 | $8.65M |
| X4003 | 10% | 94,446 | 81,206 | $5.98M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.8% | 16,956 | 15,260 | $3.91M |
| 80053 | Comprehensive metabolic panel | 5.6% | 62,639 | 53,378 | $3.20M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.4% | 19,391 | 17,532 | $3.09M |
| 94761 | 4.8% | 25,225 | 22,612 | $2.75M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 60,201 | 50,404 | $2.43M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 7,820 | 6,954 | $2.28M |
| 81001 | 1.9% | 10,269 | 9,429 | $1.08M | |
| Y7506 | 1.7% | 934 | 877 | $979K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.6% | 9,149 | 7,979 | $942K |
192 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 13,160 | $733K |
| D7999 | <1% | 436 | $529K | |
| Y7507 | <1% | 1,297 | $514K | |
| 83690 | <1% | 4,352 | $411K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,088 | $386K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,880 | $334K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,440 | $305K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,273 | $304K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 3,186 | $303K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 981 | $287K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,722 | $280K |
| J3490 | Unclassified drugs | <1% | 12,360 | $263K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,670 | $229K |
| 84484 | <1% | 6,074 | $217K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,225 | $214K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 7,331 | $208K |
| 87088 | <1% | 3,220 | $207K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,323 | $180K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,943 | $176K |
| 81003 | <1% | 9,367 | $173K | |
| 83735 | <1% | 6,886 | $168K | |
| X4006 | <1% | 115 | $160K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,035 | $158K |
| 84436 | <1% | 1,823 | $154K | |
| 85610 | <1% | 2,836 | $153K | |
| 70310 | <1% | 81 | $116K | |
| 92567 | <1% | 2,952 | $94K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,416 | $94K |
| 84702 | <1% | 1,347 | $86K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,321 | $79K |
| 86140 | <1% | 498 | $75K | |
| 81002 | <1% | 955 | $75K | |
| 85730 | <1% | 1,822 | $71K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 879 | $69K |
| 87081 | <1% | 740 | $69K | |
| 81025 | <1% | 888 | $68K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 946 | $63K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 96 | $54K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 581 | $50K |
| 73630 | <1% | 1,592 | $47K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,007 | $44K |
| 86900 | <1% | 616 | $42K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,339 | $41K |
| G0378 | Hospital observation service, per hour | <1% | 93 | $35K |
| 82553 | <1% | 150 | $33K | |
| 82550 | <1% | 164 | $33K | |
| 80061 | Lipid panel | <1% | 3,263 | $32K |
| 83880 | <1% | 935 | $32K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 328 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 751 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 994 | $26K |
| 86850 | <1% | 829 | $24K | |
| 85027 | <1% | 473 | $24K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 295 | $23K |
| 80143 | <1% | 1,612 | $22K | |
| 80179 | <1% | 1,611 | $22K | |
| 82077 | <1% | 1,761 | $22K | |
| 29581 | <1% | 469 | $21K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 395 | $20K |
| 87430 | <1% | 61 | $19K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 339 | $18K |
| 88312 | <1% | 277 | $18K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 110 | $18K |
| 59025 | Fetal non-stress test | <1% | 135 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,678 | $17K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 251 | $17K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 168 | $16K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,076 | $16K |
| 97597 | <1% | 288 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 728 | $15K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 128 | $14K |
| 90870 | <1% | 80 | $14K | |
| 86901 | <1% | 616 | $13K | |
| 96367 | <1% | 219 | $13K | |
| 83655 | <1% | 1,261 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 326 | $12K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 561 | $12K |
| 84439 | <1% | 1,854 | $12K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 106 | $12K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 173 | $11K |
| 11721 | <1% | 4,520 | $11K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 344 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 141 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,226 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 41 | $8K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 69 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 79 | $7K |
| 77336 | <1% | 105 | $7K | |
| 83605 | <1% | 607 | $7K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 117 | $6K |
| 86780 | <1% | 724 | $6K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 675 | $6K |
| 82728 | <1% | 709 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 88 | $5K |
| 97602 | <1% | 128 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 99 | $5K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 66 | $5K |
| 87660 | <1% | 310 | $5K | |
| 36592 | <1% | 122 | $4K | |
| 93296 | <1% | 475 | $4K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 24 | $4K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 244 | $4K |
| 80081 | <1% | 63 | $4K | |
| 92557 | <1% | 91 | $4K | |
| 76820 | <1% | 141 | $4K | |
| 87634 | <1% | 60 | $3K | |
| 11730 | <1% | 33 | $3K | |
| 85007 | <1% | 42 | $3K | |
| 0352U | <1% | 38 | $3K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 24 | $3K |
| 62323 | <1% | 38 | $3K | |
| 69210 | <1% | 178 | $3K | |
| 83550 | <1% | 576 | $3K | |
| 87480 | <1% | 190 | $3K | |
| 87040 | <1% | 153 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 175 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 115 | $2K |
| 86803 | <1% | 201 | $2K | |
| 83540 | <1% | 593 | $2K | |
| 85652 | <1% | 105 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 40 | $2K |
| 93922 | <1% | 67 | $2K | |
| 93880 | <1% | 29 | $2K | |
| 90715 | <1% | 59 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 27 | $2K |
| 83615 | <1% | 524 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 153 | $1K |
| 43249 | <1% | 13 | $1K | |
| 20611 | <1% | 15 | $1K | |
| 17311 | <1% | 14 | $1K | |
| 97032 | <1% | 161 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $926.00 |
| 82746 | <1% | 149 | $920.22 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $893.67 |
| 87150 | <1% | 41 | $877.49 | |
| 82607 | <1% | 138 | $876.93 | |
| 94726 | <1% | 13 | $857.08 | |
| 87340 | <1% | 149 | $852.91 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 59 | $821.22 |
| 95115 | <1% | 118 | $775.59 | |
| 94060 | <1% | 12 | $719.52 | |
| 92552 | <1% | 39 | $683.12 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 83 | $679.17 |
| 86762 | <1% | 64 | $613.09 | |
| 87186 | <1% | 105 | $588.13 | |
| 87077 | <1% | 103 | $581.34 | |
| 87510 | <1% | 44 | $566.35 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 46 | $548.35 |
| 87070 | <1% | 152 | $537.06 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 445 | $533.19 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 47 | $517.23 |
| 87075 | <1% | 121 | $502.64 | |
| 0071A | <1% | 32 | $480.00 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 62 | $412.67 |
| 85018 | <1% | 311 | $374.01 | |
| 87205 | <1% | 161 | $373.95 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 15 | $310.31 |
| 0072A | <1% | 16 | $280.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 14 | $272.80 |
| 85045 | <1% | 166 | $257.31 | |
| A6210 | Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing | <1% | 117 | $252.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 37 | $237.18 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 74 | $224.64 |
| 92555 | <1% | 29 | $192.33 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 15 | $187.34 |
| 80305 | <1% | 26 | $168.96 | |
| 97162 | <1% | 18 | $142.93 | |
| 85046 | <1% | 41 | $128.05 | |
| 87807 | <1% | 15 | $97.16 | |
| 82962 | <1% | 76 | $94.42 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 27 | $90.15 |
| 88720 | <1% | 15 | $71.33 | |
| 93299 | <1% | 31 | $66.61 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 466 | $58.48 |
| 92558 | <1% | 42 | $57.19 | |
| 82947 | <1% | 15 | $54.14 | |
| 82950 | <1% | 12 | $37.14 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 15 | $34.20 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $12.91 |
| 94729 | <1% | 12 | $11.75 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 968 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 13 | $0.00 |
| G9920 | Screening performed and negative | 0% | 16 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 14 | $0.00 |
| 90686 | 0% | 58 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 101 | $0.00 |
| 80050 | General health panel | 0% | 42 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 14 | $0.00 |
| A9270 | Non-covered item or service | 0% | 207 | $0.00 |
| 94760 | 0% | 17 | $0.00 | |
| 92551 | 0% | 13 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATTERSON, CINDY (PROVIDER ENROLLMENT SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Heartland Regional Medical Center | Saint Joseph, MO | $2.47M |
| Heartland Regional Medical Center | Saint Joseph, MO | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.